![Eric Hughes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Hughes
Chief Tech/Sci/R&D Officer at
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Net worth: 5 M $ as of 2026-08-30
Profile
Dr. Eric A. Hughes is an Independent Director at Monte Rosa Therapeutics, Inc. and a Chief Medical Officer, Executive VP-Global R&D at Teva Pharmaceutical Industries Ltd. He is on the Board of Directors at Monte Rosa Therapeutics, Inc. Dr. Hughes was previously employed as a SVP-Clinical Development & Translational Medicine by Vertex Pharmaceuticals, Inc. He received his graduate degree from Yale School of Medicine and a doctorate degree from Yale School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-02 | 134,877 ( 0.01% ) | 5 M $ | 2026-08-30 | |
| 2026-06-10 | 0 ( -.--% ) | - $ | 2026-08-30 |
Eric Hughes active positions
| Companies | Position | Start |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Tech/Sci/R&D Officer | 2022-07-31 |
| MONTE ROSA THERAPEUTICS, INC. | Director/Board Member | 2024-12-12 |
Former positions of Eric Hughes
| Companies | Position | End |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Training of Eric Hughes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Eric Hughes
